• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

NIVOLUMAB

Immune checkpoint blockade in cancer immunotherapy

August 28, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Immune checkpoint blockade in cancer immunotherapy

Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit. Explore the live graph.

Vizit Graphs Tag Cloud

STAPHYLOCOCCUS AUREUS IL17A ESCHERICHIA COLI AGING INSULIN ANGIOGENESIS CELL DEATH DOXORUBICIN TP53 PORPHYROMONAS GINGIVALIS TNF IL23A CANCER 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE CASP3 TH17 CELLS CELL DIFFERENTIATION ERBB-2 CELL DIVISION BREAST CANCER IFNG IMMUNE RESPONSE NEURODEGENERATIVE DISORDERS SOD1 APOPTOTIC PROCESS METFORMIN RHEUMATOID ARTHRITIS CD4 INFLAMMATION REMICADE PSEUDOMONAS AERUGINOSA CANDIDA ALBICANS RECEPTOR IL6 AUTOPHAGY CTLA4 PARKINSON DISEASE ALZHEIMER'S DISEASE CLOSTRIDIUM DIFFICILE DIABETES MELLITUS FOXP3 STREPTOCOCCUS PNEUMONIAE LISTERIA MONOCYTOGENES CELL PROLIFERATION HELICOBACTER PYLORI

© 2019 Biovista Vizit All Rights Reserved.